Syros Pharmaceuticals' IPO

Syros Pharmaceuticals raised a round of funding on June 30, 2016. Investors include Public.

Syros Pharmaceuticals is a therapeutics company working in gene control to develop the treatment of cancer and other diseases. Syros' platform identifies the master switches for disease genes, opening…

Articles about Syros Pharmaceuticals' IPO: